Answer
Nerlynx (neratinib maleate) inhibits P-glycoprotein efflux transporters and increased digoxin Cmax by 54% and AUC by 32% in a clinical study, so patients receiving both medicines should be carefully monitored.
Sources for this answer
- Nerlynx 40 mg film-coated tabletsPierre Fabre Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 13Document updated
Sources checked